PhotoMedex shares should be bought on weakness, says Maxim

theflyonthewall.com

After PhotoMedex reported higher than expected EPS but lower than expected revenue, Maxim believes that several positive catalysts should boost the company's revenues. The firm expects the company to gain market share and maintains a Buy rating.

Rates

View Comments (0)